A Phase 1b Trial of the Combination of Capecitabine and Erlotinib in Advanced Lung Cancer

被引：0
|
作者：
Kumar, Rajiv [1 ]
Lo, Karl [1 ]
Minchom, Anna R. [1 ]
Sharp, Adam [1 ]
Davidson, Michael [1 ]
Gunapala, Ranga [1 ]
Yap, Timothy [2 ,3 ]
Bhosle, Jaishree [1 ]
Popat, Sanjay [1 ]
O'Brien, Mary E. R. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Dept Lung Med, London, Surrey, England
[2] Inst Canc Res, Dept Lung Med, London, Surrey, England
[3] Royal Marsden NHS Fdn Trust, London, Surrey, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Erlotinib; Capecitabine; Non-small-cell lung cancer; Phase; 1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-077
引用
收藏
页码：S547 / S548
页数：2
相关论文
共 50 条
  • [31] Phase 1b trial of LY2606368 in combination with chemoradiation in patients with locally advanced head and neck squamous cell cancer
    Yang, E.
    William, W.
    Fayette, J.
    Zhang, W.
    Fink, A.
    Lin, A. B.
    Deutsch, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study
    Cohen, Steven J.
    O'Neil, Bert H.
    Berlin, Jordan
    Ames, Patricia
    McKinley, Marti
    Horan, Julie
    Catalano, Patricia M.
    Davies, Angela
    Weekes, Colin D.
    Leichman, Lawrence
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (04) : 693 - 701
  • [33] First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer
    Winer, Arthur
    Denlinger, Crystal S.
    Vijayvergia, Namrata
    Cohen, Steven J.
    Astaturov, Igor
    Dotan, Efrat
    Gallant, Jean-Nicolas
    Wang, Edward W.
    Kunkel, Miriam
    Lim, Bora
    Harvey, Harold A.
    Sivik, Jeffrey
    Korzekwa, Kenneth
    Ruth, Karen
    White, Kevin
    Cooper, Harry S.
    Ross, Eric A.
    Zhou, Lanlan
    El-Deiry, Wafik S.
    CLINICAL COLORECTAL CANCER, 2021, 20 (01) : E43 - E52
  • [34] A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study
    Steven J. Cohen
    Bert H. O’Neil
    Jordan Berlin
    Patricia Ames
    Marti McKinley
    Julie Horan
    Patricia M. Catalano
    Angela Davies
    Colin D. Weekes
    Lawrence Leichman
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 693 - 701
  • [35] Phase II trial of capecitabine ± erlotinib in advanced colorectal cancer, with retrospective KRAS and primary tumor site analysis.
    Breadner, Daniel Adam
    Welch, Stephen
    Soulieres, Denis
    Sanatani, Michael Susmoy
    Klimo, Paul
    MacKenzie, Mary J.
    Whiston, Frances
    Stitt, Larry
    O'Connell, Anne
    Vincent, Mark David
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [36] A PHASE 1B/2 STUDY OF CABOZANTINIB IN COMBINATION WITH PEMBROLIZUMAB IN ADVANCED MELANOMA
    Jain, Jayanshu
    Frees, Melanie
    Yasin, Hesham
    Bonner, Jaime
    Freesmeier, Michele
    Garje, Rohan
    Venur, Vyshak Alva
    Milhem, Mohammed
    Zakharia, Yousef
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A260 - A260
  • [37] Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study
    Kotasek, Dusan
    Tebbutt, Niall
    Desai, Jayesh
    Welch, Stephen
    Siu, Lillian L.
    McCoy, Sheryl
    Sun, Yu-Nien
    Johnson, Jessica
    Adewoye, Adeboye H.
    Price, Timothy
    BMC CANCER, 2011, 11
  • [38] Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study
    Dusan Kotasek
    Niall Tebbutt
    Jayesh Desai
    Stephen Welch
    Lillian L Siu
    Sheryl McCoy
    Yu-Nien Sun
    Jessica Johnson
    Adeboye H Adewoye
    Timothy Price
    BMC Cancer, 11
  • [39] A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer
    Sanghvi, Samrat M.
    Coffman, Alex R.
    Hsueh, Chung-Tsen
    Kang, Joseph
    Park, Annie
    Solomon, Naveenraj L.
    Garberoglio, Carlos A.
    Reeves, Mark E.
    Slater, Jerry D.
    Yang, Gary Y.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 1989 - 1996
  • [40] Phase 1b Trial of Cabozantinib or Cabozantinib Plus Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Lim, F.
    Ponce, S.
    Patel, S.
    Van Herpen, C.
    Kurkjian, C.
    Lou, Y.
    Liu, Y.
    Ramsingh, G.
    Pal, S.
    Neal, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S405 - S406
12345